GlassScriptPhysician profile
Nathan F Boyd
NPI 1679831184
$1,858.54
in general payments reported to CMS, 2019-2025
8 companies · $456 in 2025
The $456 reported for 2025 was more than what 89% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.06 · 2022: $198 · 2023: $870 · 2024: $249 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerr Corporation | $674.95 | 2021-2023 | Zirconia Abutment Preparation Kit, Harmonize, Tf Adaptive |
| Envista Holdings Corporation | $639.06 | 2024-2025 | Optibond Solo Plus, Zirconia Abutment Preparation Kit, Harmonize |
| Nobel Biocare USA | $411.19 | 2023 | Nobelactive |
| Dentsply Sirona INC | $45.77 | 2025 | Surefil Sdr Flow+ Bulk Fill Flowable |
| 3m Company | $41.02 | 2022-2023 | Filtek |
| Biohorizons Implant Systems INC. | $19.44 | 2025 | Biohorizons Dental Prosthetics |
| Metrex Research, LLC | $14.00 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.